Načítá se...
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model
BACKGROUND: This study was designed to test a new approach to drug treatment of autism spectrum disorders (ASDs) in the Fragile X (Fmr1) knockout mouse model. METHODS: We used behavioral analysis, mass spectrometry, metabolomics, electron microscopy, and western analysis to test the hypothesis that...
Uloženo v:
| Vydáno v: | Mol Autism |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334917/ https://ncbi.nlm.nih.gov/pubmed/25705365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2040-2392-6-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|